×
Entrez Id:
4683
Gene Symbol:
NBN
NBN
0.610
Biomarker
disease
GENOMICS_ENGLAND
Germline Genetic Predisposition to Hematologic Malignancy.
28297620
2017
SLC22A18
0.310
GeneticVariation
disease
UNIPROT
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
0.290
Biomarker
disease
RGD
Methylation of RAR-β2, RASSF1A, and CDKN2A genes induced by nickel subsulfide and nickel-carcinogenesis in rats.
21565688
2011
×
Entrez Id:
285
Gene Symbol:
ANGPT2
ANGPT2
0.200
Biomarker
disease
RGD
Zone-specific remodeling of tumor blood vessels affects tumor growth.
17849463
2007
×
Entrez Id:
4683
Gene Symbol:
NBN
NBN
0.610
Biomarker
disease
HPO
×
Entrez Id:
5727
Gene Symbol:
PTCH1
PTCH1
0.500
Biomarker
disease
HPO
×
Entrez Id:
3265
Gene Symbol:
HRAS
HRAS
0.450
Biomarker
disease
HPO
×
Entrez Id:
23405
Gene Symbol:
DICER1
DICER1
0.440
Biomarker
disease
HPO
×
Entrez Id:
701
Gene Symbol:
BUB1B
BUB1B
0.420
Biomarker
disease
HPO
×
Entrez Id:
5395
Gene Symbol:
PMS2
PMS2
0.410
Biomarker
disease
HPO
×
Entrez Id:
4893
Gene Symbol:
NRAS
NRAS
0.130
Biomarker
disease
HPO
×
Entrez Id:
4763
Gene Symbol:
NF1
NF1
0.130
Biomarker
disease
HPO
×
Entrez Id:
4292
Gene Symbol:
MLH1
MLH1
0.100
Biomarker
disease
HPO
×
Entrez Id:
4157
Gene Symbol:
MC1R
MC1R
0.100
Biomarker
disease
HPO
×
Entrez Id:
699
Gene Symbol:
BUB1
BUB1
0.100
Biomarker
disease
HPO
×
Entrez Id:
2956
Gene Symbol:
MSH6
MSH6
0.100
Biomarker
disease
HPO
×
Entrez Id:
9702
Gene Symbol:
CEP57
CEP57
0.100
Biomarker
disease
HPO
×
Entrez Id:
4436
Gene Symbol:
MSH2
MSH2
0.100
Biomarker
disease
HPO
×
Entrez Id:
9184
Gene Symbol:
BUB3
BUB3
0.100
Biomarker
disease
HPO
×
Entrez Id:
9319
Gene Symbol:
TRIP13
TRIP13
0.100
Biomarker
disease
HPO
×
Entrez Id:
3265
Gene Symbol:
HRAS
HRAS
0.450
GeneticVariation
disease
LHGDN
Uniparental disomy at chromosome 11p15.5 followed by HRAS mutations in embryonal rhabdomyosarcoma: lessons from Costello syndrome.
17164262
2007
×
Entrez Id:
4654
Gene Symbol:
MYOD1
MYOD1
0.400
Biomarker
disease
LHGDN
Polyclonal desmin and muscle-specific actin were variably immunoreactive in UESL and RMS ; however, myogenin and myogenic regulatory protein D1 (MyoD1 ) were uniformly negative in UESL and routinely positive in the majority of biliary tract RMS .
17378682
2007
×
Entrez Id:
4654
Gene Symbol:
MYOD1
MYOD1
0.400
AlteredExpression
disease
LHGDN
Detection of bone marrow micrometastasis and microcirculating disease in rhabdomyosarcoma by a real-time RT-PCR assay.
16435141
2006
×
Entrez Id:
7422
Gene Symbol:
VEGFA
VEGFA
0.380
Biomarker
disease
LHGDN
Vascular endothelial growth factor acts in an autocrine manner in rhabdomyosarcoma cell lines and can be inhibited with all-trans-retinoic acid.
16116481
2005
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
0.290
Biomarker
disease
LHGDN
The marked synergism in mice between aberrant c-Met signaling and Ink4a /Arf inactivation, lesions individually implicated in human RMS , suggests a therapeutic combination to combat this devastating childhood cancer.
12368906
2002